PR Newswire·Aug 13, 2026, 4:10 PM ET

cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026

YCBD

cbdMD, Inc. reported a 20% year-over-year increase in third-quarter fiscal 2026 net sales to $5.6 million, driven by a 61% rise in wholesale revenue.
Wholesale net sales grew to $1.7 million, while direct-to-consumer sales reached $3.9 million, accounting for 70% of total revenue.
The acquired Bluebird Botanicals brand contributed its first full quarter of revenue, generating over $0.5 million in the third quarter.
The Oasis beverage brand expanded distribution to South Carolina, secured a new Texas partner quadrupling store access, and saw distributor depletions grow 25%.
Oasis launched a zero-proof Kava beverage, with additional natural compounds anticipated before the end of the calendar year.
Revenue growth was offset by a loss from operations of $1.13 million due to one-time M&A due diligence, legal costs, product development, and inventory reserves.
Non-GAAP Adjusted EBITDA loss improved to approximately $508,000 from $624,000 in the prior-year quarter.
Net loss attributable to common shareholders was approximately $1.2 million, or $0.11 per share, compared to $0.21 per share in the previous year.
The company implemented cost-reduction initiatives in July targeting monthly savings of $100,000 to $150,000 to improve financial flexibility.
A Senate-driven extension temporarily exempts naturally occurring cannabinoids from certain THC limits under H.R. 5371 Section 781 until December 11, 2026.
Bipartisan legislative momentum continues with the introduction of the Beverage Regulatory Parity Act to regulate hemp-derived beverages similarly to alcohol.
At June 30, 2026, the company held working capital of approximately $4.7 million and cash on hand of $2.1 million.